ditiocarb has been researched along with Cholangiocellular Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, H; Kariya, R; Kudo, E; Okada, S; Srikoon, P; Taura, M; Vaeteewoottacharn, K; Wongkham, S | 1 |
1 other study(ies) available for ditiocarb and Cholangiocellular Carcinoma
Article | Year |
---|---|
Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Chelating Agents; Cholangiocarcinoma; Ditiocarb; Electrophoretic Mobility Shift Assay; Humans; Intercellular Adhesion Molecule-1; NF-kappa B; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Wound Healing | 2013 |